학술논문

Dose Selection and Clinical Development of Efgartigimod PH20 Subcutaneous in Patients with Generalized Myasthenia Gravis
Document Type
Journal
Source
NEUROLOGY; APR 25 2023, 100 17, p4131 7p. Supplement: 2
Subject
Language
English
ISSN
1526632X